Loading…

MicroPort Scientific Corporation, through its subsidiary MicroPort Surgery, acquired 100% of Hemovent GmbH for a total cash consideration of up to €123 million. Hemovent becomes a wholly-owned subsidiary of MicroPort.
“MicroPort® announced on October 4th, 2021, through its critical care subsidiary, MicroPort® Surgery, has acquired 100% of the equity held by existing shareholders of Hemovent GmbH for a total cash consideration of up to €123 million.”microport.com
Summarized from public sources; check the original articles before acting on it.